Use of avexitide in patients with post-bariatric hypoglycaemia and hyperinsulinemic hypoglycaemiaPhase 2b results of avexitide (Eiger BioPharmaceuticals) in patients with post-bariatric hypoglycemia (PBH) and hyperinsulinemic...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomes4 hours ago